Results 11 to 20 of about 18,694 (205)
A case of human monocytic ehrlichiosis in Serbia [PDF]
Srpski Arhiv za Celokupno Lekarstvo, 2014 Introduction. Ehrlichiosis is a bacterial zoonosis transmitted by hematophagous arthropods - ticks. In humans, it occurs as monocytic, granulocytic, and ewingii ehrlichiosis.
Arsić Bogdan +6 more
doaj +6 more sources
Overview of Canine Monocytic Ehrlichiosis
, 2023 Canine monocytic ehrlichiosis is a serious tick-transmitted, globally distributed disease of dogs that is caused by Ehrlichia canis. It primarily affects platelets, monocytes, and granulocytes. Acute infections in dogs respond favourably to therapy, however chronic disease results in bone marrow failure and death.
Dr. M. Fibi Rani1*, Dr. J. Shashank2
openaire +3 more sources
Monocytic Ehrlichiosis in dogs [PDF]
Polish Journal of Veterinary Sciences, 2011 Ehrlichiosis is the multiorgan infectious disease caused by small, intracellular rickettsias from the genus Ehrlichia. These microorganisms are known as an etiologic factor of infections world wide in humans and in different species of animals. Dog ehrlichiosis can be caused by several species of Ehrlichia attacking different groups of blood cells, but
A, Procajło +3 more
openaire +3 more sources
Comparative evaluation of four drugs on hematology and recovery time of canine monocytic Ehrlichiosis [PDF]
Iraqi Journal of Veterinary SciencesCanine monocytic ehrlichiosis causes acute, sub-clinical, and chronic clinical complications with changes in hematological parameters: hemoglobin, hematocrit, and white blood cell count; doxycycline is suitable for treatment.
Pruler Pillco +3 more
doaj +3 more sources
Serologic Evidence of Human Monocytic and Granulocytic Ehrlichiosis in Israel
Emerging Infectious Diseases, 1999 We conducted a retrospective serosurvey of 1,000 persons in Israel who had fever of undetermined cause to look for Ehrlichia chaffeensis antibodies. Four of five cases with antibodies reactive to E.
Avi Keysary +8 more
doaj +3 more sources
Successful Treatment of Human Monocytic Ehrlichiosis with Rifampin. [PDF]
Cureus, 2016 Currently recommended treatment regimens for human monocytic ehrlichiosis (HME) include doxycycline or tetracycline. Antibiotic susceptibility studies demonstrate that rifampin has in vitro bactericidal activity against Ehrlichia. Case reports have suggested clinical response with rifampin treatment of human granulocytic anaplasmosis (HGA).
Abusaada K, Ajmal S, Hughes L.
europepmc +4 more sources
Canine Monocytic Ehrlichiosis among working dogs of organised kennels in India: A comprehensive analyses of clinico-pathology, serological and molecular epidemiological approach [PDF]
Preventive Veterinary Medicine, 2017 Mitesh Mittal +2 more
exaly +2 more sources
Ehrlichiosis mimicking acute leukemia
IDCases, 2022 Human monocytic ehrlichiosis is a tickborne disease with a spectrum of presentations ranging from asymptomatic, mild to fatal. Ehrlichiosis can transiently cause white blood cells abnormalities that mimic leukemia/lymphoma and cases have been, on rare ...
Ra’ed Jabr, Wissam El Atrouni
doaj +1 more source
Multiorgan failure related to human monocytic ehrlichiosis. [PDF]
BMJ Case Rep, 2013 Human monocytic ehrlichiosis (HME) is a tick-born disease that presents predominantly as a mild to moderate acute illness. Severe life-threatening disease has been reported with a case death rate of approximately 3%, often in immunosuppressed persons. A delay in therapy initiation has been proven to increase the morbidity of the disease.
Yachoui R.
europepmc +4 more sources
Archives of Veterinary Medicine, 2015 Canine monocytic ehrlichiosis is a bacterial, vector-transmitted infection caused by Ehrlichia canis. Th e pathogen is mainly transmitted by ticks Rhipicephalus sanguineus.
Aleksandar Potkonjak +6 more
doaj +1 more source